Corcept Therapeutics (CORT) Stock Forum and Discussion

26.540 -0.190-0.71% Close 12/08 16:00 ET

26.980High26.460Low369.62KVolume

Corcept Therapeutics Stock Forum

Investors see Corcept Therapeutics's EPS decrease and rising share price, plus its positive revenue growth hinting at expansion. Despite a 1.3% loss this year, 17% annual gains over the past five years present an attractive investment opportunity.

Optimism for Corcept Therapeutics (NASDAQ:CORT) Has Grown This Past Week, Despite Five-year Decline in Earnings

Moomoo Breakfast US

09/23/2022 20:59

ColumnsToday's Pre-Market Stock Movers: QCOM, BA, ROKU, AZN and More

Gapping up
In reaction to earnings/guidance:
• $CalAmp(CAMP.US)$ +0.6%
Other news:
• $Cano Health(CANO.US)$ +6.1% ($Humana(HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics(CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial(LPLA.US)$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona(XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +2.9% (tr...

Moomoo Breakfast US

03/31/2022 20:53

ColumnsToday's pre-market stock movers: CLVS, PATH, DARE and more

Gainers:
• $Clovis Oncology(CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US)$ +9.5% (secured a battery sa...